Cellect Biotechnology (NASDAQ, TASE:APOP) CEO, Dr. Shai Yarkoni, was selected to provide the keynote presentation at the 11th World Congress of Regenerative Medicine and Stem Cell Technologies in Singapore.
The event is intended to provide a platform for professionals around the world to exchange state-of-the-art research and development and identify business trends, needs and opportunities in the field of regenerative medicine and stem cells.
In a statement, Dr. Yarkoni said the company is actively seeking business development opportunities in the Far East.
“There are far reaching advancements in the region with regards to regenerative medicine and stem cells technologies,” he added. “Events such as this provide the business opportunities and wealth of information exchange we aspire to.”
Dr. Yarkoni said the conference is taking place in Singapore pointing to the increasing importance of the Asian arena in the area of stem cell corporate development
